Article Information
History
- June 30, 2020.
Article Versions
- Version 1 (June 26, 2020 - 15:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rory Henderson1,2,*,
- Robert J Edwards1,2,
- Katayoun Mansouri1,
- Katarzyna Janowska1,
- Victoria Stalls1,
- Megan Kopp1,
- Barton F. Haynes1,2,4 and
- Priyamvada Acharya1,5,*
- 1Duke Human Vaccine Institute, Durham NC 27710, USA
- 2Duke University, Department of Medicine, Durham NC 27710, USA
- 4Duke University, Department of Immunology, Durham NC 27710, USA
- 5Duke University, Department of Surgery, Durham NC 27710, USA
- ↵*To whom correspondence should be addressed, Correspondence to: Rory Henderson (rory.henderson{at}duke.edu) and Priyamvada Acharya (priyamvada.acharya{at}duke.edu)
Posted June 30, 2020.
Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
